Form 4: Accolade Inc. President Cavanaugh Reports Stock Transactions

Robert N. Cavanaugh, President of Accolade, Inc., reports the conversion of Restricted Stock Units (RSUs) and a sale of shares to cover tax obligations.

Summary

• On March 17, 2025, Accolade, Inc. President Robert N. Cavanaugh converted 510 Restricted Stock Units (RSUs) into common stock at a price of $0.
• Following this transaction, Cavanaugh directly owns 218,878 shares of Accolade, Inc. common stock.
• On March 18, 2025, Cavanaugh sold 181 shares of common stock at $6.985 per share to cover tax withholding obligations related to the vesting of RSUs.
• After the sale, Cavanaugh directly owns 218,697 shares of Accolade, Inc. common stock.
• The RSUs vest over four years from the June 16, 2021 Vesting Commencement Date, with 25% vesting on the first anniversary and the remainder vesting monthly thereafter.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives, ensuring compliance with SEC regulations.
• Similar filings are made by executives at comparable companies like Teladoc Health or Livongo, when they exercise options or sell shares.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.
• The sale of shares to cover tax obligations is a common practice and generally does not significantly affect stakeholder confidence.

Key Dates